OptiBiotix Health Plc

5.60pAs of Sun 8 Nov 2026, 12:00 UTC
LSE:OPTIHealthcare
Ctry United Kingdom
PE (Fwd) •••
TSR 10Y CAGR (22.22%)
Div yield —
ROE (65.19%)
Biotechnology
Beta (5Y) 1.75
PE TTM —
TSR TTM (30.00%)
Mkt cap £5.785M
ROIC (23.28%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
6.25p
11.57%
267.70%
Hold 6|10|8|8|4
4Q25
1Q26
2Q26
3Q26
Earnings per share£
0.08
0.08
0.08
0.09
23.90%
21.22%
18.03%
22.09%
Revenue£M
0.405
0.404
0.414
0.411
14.39%
8.84%
9.26%
6.51%
Peers (US$7.784M)
Cap (US$)
PE
7.761M
—
Capital
TTM
5Y
10Y
Leveragex
0.144
—
—
EBIT/Intx
1.899
0.292
0.263
Own earn%
(352.76)
19.76
10.37
Sh yield%
26.78
35.59
27.44
Owners
Insiders/Inst%
10.98
42.43
Short interest%
5.19
SBC / revenue%
3.45
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
4–10
$1 testx
—
Incr. ROIC%
3